1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome

3. Executive Summary

3.1. Introduction
3.2. Market Outlook
3.3. Component Outlook
3.4. End-User Outlook
3.5. Therapeutic Area Outlook
3.6. Geography Outlook
3.7. Competitor Outlook

4. Market Overview

4.1. Introduction

5. Market Dynamics

5.1. Introduction
5.2. Drivers
5.2.1. Shift from volume to value based care
5.2.2. Delays in drug development and the subsequent increase in development costs
5.2.3. Drug safety and effectiveness after clinical trials
5.3. Restraints
5.3.1. Reluctance to rely on real-world studies
5.4. Opportunities
5.4.1. Rising focus on end-to-end RWE services
5.4.2. Emerging roles of wearable devices and AI in RWE
5.5. Challenges
5.5.1. Lack of universally accepted methodological standards and data processing infrastructure

6. Market Insights

6.1. Porters Five Forces Analysis
6.1.1. Threat of New Entrants
6.1.2. Threat of Substitutes
6.1.3. Bargaining Power of Customers
6.1.4. Bargaining Power of Suppliers
6.1.5. Industry Rivalry
6.2. Cumulative Impact of COVID-19

7. Global Real World Evidence Solution Market, By Component

7.1. Introduction
7.2. Data Set
7.2.1. Claims Data
7.2.2. Clinical Settings Data
7.2.3. Patient-Powered Data
7.2.4. Pharmacy Data
7.3. Services

8. Global Real World Evidence Solution Market, By Therapeutic Area

8.1. Introduction
8.2. Cardiovascular
8.3. Immunology
8.4. Infectious Diseases
8.5. Neurology
8.6. Oncology

9. Global Real World Evidence Solution Market, By End-User

9.1. Introduction
9.2. Biopharmaceutical Company
9.3. Clinical & Life Sciences Organization
9.4. Diagnostics or Medical Device Company

10. Americas Real World Evidence Solution Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Real World Evidence Solution Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. South Korea
11.10. Thailand

12. Europe, Middle East & Africa Real World Evidence Solution Market

12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom

13. Competitive Landscape

13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion

14. Company Usability Profiles

14.1. Certara, L.P.
14.2. Clinigen Group PLC
14.3. Cognizant Technology Solutions Corp.
14.4. HealthiVibe, LLC
14.5. IBM Corporation
14.6. ICON PLC
14.7. IQVIA
14.8. Mercy Technology Services
14.9. Oracle Corporation
14.10. PAREXEL International Corporation
14.11. Pharmaceutical Product Development, LLC
14.12. SAS Institute, Inc.
14.13. Sciformix Corporation
14.14. Syneos Health
14.15. Turacoz

15. Appendix

15.1. Discussion Guide

List of Figures

FIGURE 1. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2019 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2019 VS 2025 (USD MILLION)
FIGURE 5. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2019 VS 2025 (USD MILLION)
FIGURE 6. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2019 VS 2025 (USD MILLION)
FIGURE 7. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
FIGURE 8. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 9. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (%)
FIGURE 10. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 12. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET: MARKET DYNAMICS
FIGURE 13. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 14. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2019 VS 2025 (%)
FIGURE 15. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2019 VS 2025 (USD MILLION)
FIGURE 16. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2025
FIGURE 17. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY DATA SET, 2019 VS 2025 (USD MILLION)
FIGURE 18. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY CLAIMS DATA, 2019 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY CLINICAL SETTINGS DATA, 2019 VS 2025 (USD MILLION)
FIGURE 20. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY PATIENT-POWERED DATA, 2019 VS 2025 (USD MILLION)
FIGURE 21. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY PHARMACY DATA, 2019 VS 2025 (USD MILLION)
FIGURE 22. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY SERVICES, 2019 VS 2025 (USD MILLION)
FIGURE 23. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2019 VS 2025 (%)
FIGURE 24. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2019 VS 2025 (USD MILLION)
FIGURE 25. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2025
FIGURE 26. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY CARDIOVASCULAR, 2019 VS 2025 (USD MILLION)
FIGURE 27. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY IMMUNOLOGY, 2019 VS 2025 (USD MILLION)
FIGURE 28. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY INFECTIOUS DISEASES, 2019 VS 2025 (USD MILLION)
FIGURE 29. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY NEUROLOGY, 2019 VS 2025 (USD MILLION)
FIGURE 30. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY ONCOLOGY, 2019 VS 2025 (USD MILLION)
FIGURE 31. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2019 VS 2025 (%)
FIGURE 32. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2019 VS 2025 (USD MILLION)
FIGURE 33. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2025
FIGURE 34. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY BIOPHARMACEUTICAL COMPANY, 2019 VS 2025 (USD MILLION)
FIGURE 35. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY CLINICAL & LIFE SCIENCES ORGANIZATION, 2019 VS 2025 (USD MILLION)
FIGURE 36. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY DIAGNOSTICS OR MEDICAL DEVICE COMPANY, 2019 VS 2025 (USD MILLION)
FIGURE 37. AMERICAS REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (%)
FIGURE 38. AMERICAS REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
FIGURE 39. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 40. ARGENTINA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 41. BRAZIL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 42. CANADA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 43. MEXICO REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 44. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 45. ASIA-PACIFIC REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (%)
FIGURE 46. ASIA-PACIFIC REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
FIGURE 47. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 48. AUSTRALIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 49. CHINA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 50. INDIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 51. INDONESIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 52. JAPAN REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 53. MALAYSIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 54. PHILIPPINES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 55. SOUTH KOREA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 56. THAILAND REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 57. EUROPE, MIDDLE EAST & AFRICA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (%)
FIGURE 58. EUROPE, MIDDLE EAST & AFRICA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
FIGURE 59. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 60. FRANCE REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 61. GERMANY REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 62. ITALY REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 63. NETHERLANDS REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 64. QATAR REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 65. RUSSIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 66. SAUDI ARABIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 67. SOUTH AFRICA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 68. SPAIN REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 69. UNITED ARAB EMIRATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 70. UNITED KINGDOM REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 71. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 72. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 73. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET, BY TYPE

List of Tables

TABLE 1. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, 2017-2025 (USD MILLION)
TABLE 2. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 3. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2017-2025 (USD MILLION)
TABLE 4. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY DATA SET, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 5. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY CLAIMS DATA, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 6. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY CLINICAL SETTINGS DATA, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 7. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY PATIENT-POWERED DATA, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 8. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY PHARMACY DATA, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 9. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY SERVICES, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 10. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
TABLE 11. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY CARDIOVASCULAR, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 12. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY IMMUNOLOGY, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 13. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY INFECTIOUS DISEASES, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 14. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY NEUROLOGY, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 15. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY ONCOLOGY, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 16. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 17. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY BIOPHARMACEUTICAL COMPANY, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 18. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY CLINICAL & LIFE SCIENCES ORGANIZATION, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 19. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY DIAGNOSTICS OR MEDICAL DEVICE COMPANY, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 20. AMERICAS REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 21. AMERICAS REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2017-2025 (USD MILLION)
TABLE 22. AMERICAS REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 23. AMERICAS REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
TABLE 24. ARGENTINA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2017-2025 (USD MILLION)
TABLE 25. ARGENTINA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 26. ARGENTINA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
TABLE 27. BRAZIL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2017-2025 (USD MILLION)
TABLE 28. BRAZIL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 29. BRAZIL REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
TABLE 30. CANADA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2017-2025 (USD MILLION)
TABLE 31. CANADA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 32. CANADA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
TABLE 33. MEXICO REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2017-2025 (USD MILLION)
TABLE 34. MEXICO REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 35. MEXICO REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
TABLE 36. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2017-2025 (USD MILLION)
TABLE 37. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 38. UNITED STATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
TABLE 39. ASIA-PACIFIC REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 40. ASIA-PACIFIC REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2017-2025 (USD MILLION)
TABLE 41. ASIA-PACIFIC REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 42. ASIA-PACIFIC REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
TABLE 43. AUSTRALIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2017-2025 (USD MILLION)
TABLE 44. AUSTRALIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 45. AUSTRALIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
TABLE 46. CHINA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2017-2025 (USD MILLION)
TABLE 47. CHINA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 48. CHINA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
TABLE 49. INDIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2017-2025 (USD MILLION)
TABLE 50. INDIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 51. INDIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
TABLE 52. INDONESIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2017-2025 (USD MILLION)
TABLE 53. INDONESIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 54. INDONESIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
TABLE 55. JAPAN REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2017-2025 (USD MILLION)
TABLE 56. JAPAN REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 57. JAPAN REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
TABLE 58. MALAYSIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2017-2025 (USD MILLION)
TABLE 59. MALAYSIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 60. MALAYSIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
TABLE 61. PHILIPPINES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2017-2025 (USD MILLION)
TABLE 62. PHILIPPINES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 63. PHILIPPINES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
TABLE 64. SOUTH KOREA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2017-2025 (USD MILLION)
TABLE 65. SOUTH KOREA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 66. SOUTH KOREA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
TABLE 67. THAILAND REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2017-2025 (USD MILLION)
TABLE 68. THAILAND REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 69. THAILAND REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
TABLE 70. EUROPE, MIDDLE EAST & AFRICA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 71. EUROPE, MIDDLE EAST & AFRICA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2017-2025 (USD MILLION)
TABLE 72. EUROPE, MIDDLE EAST & AFRICA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 73. EUROPE, MIDDLE EAST & AFRICA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
TABLE 74. FRANCE REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2017-2025 (USD MILLION)
TABLE 75. FRANCE REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 76. FRANCE REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
TABLE 77. GERMANY REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2017-2025 (USD MILLION)
TABLE 78. GERMANY REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 79. GERMANY REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
TABLE 80. ITALY REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2017-2025 (USD MILLION)
TABLE 81. ITALY REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 82. ITALY REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
TABLE 83. NETHERLANDS REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2017-2025 (USD MILLION)
TABLE 84. NETHERLANDS REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 85. NETHERLANDS REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
TABLE 86. QATAR REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2017-2025 (USD MILLION)
TABLE 87. QATAR REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 88. QATAR REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
TABLE 89. RUSSIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2017-2025 (USD MILLION)
TABLE 90. RUSSIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 91. RUSSIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
TABLE 92. SAUDI ARABIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2017-2025 (USD MILLION)
TABLE 93. SAUDI ARABIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 94. SAUDI ARABIA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
TABLE 95. SOUTH AFRICA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2017-2025 (USD MILLION)
TABLE 96. SOUTH AFRICA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 97. SOUTH AFRICA REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
TABLE 98. SPAIN REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2017-2025 (USD MILLION)
TABLE 99. SPAIN REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 100. SPAIN REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
TABLE 101. UNITED ARAB EMIRATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2017-2025 (USD MILLION)
TABLE 102. UNITED ARAB EMIRATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 103. UNITED ARAB EMIRATES REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
TABLE 104. UNITED KINGDOM REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY COMPONENT, 2017-2025 (USD MILLION)
TABLE 105. UNITED KINGDOM REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY END-USER, 2017-2025 (USD MILLION)
TABLE 106. UNITED KINGDOM REAL WORLD EVIDENCE SOLUTION MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
TABLE 107. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET: SCORES
TABLE 108. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET: BUSINESS STRATEGY
TABLE 109. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET: PRODUCT SATISFACTION
TABLE 110. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET: RANKING
TABLE 111. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET: MERGER & ACQUISITION
TABLE 112. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 113. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 114. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET: INVESTMENT & FUNDING
TABLE 115. GLOBAL REAL WORLD EVIDENCE SOLUTION MARKET: AWARD, RECOGNITION, & EXPANSION

Companies Mentioned

Certara, L.P.
Clinigen Group PLC
Cognizant Technology Solutions Corp.
HealthiVibe, LLC
IBM Corporation
ICON PLC
IQVIA
Mercy Technology Services
Oracle Corporation
PAREXEL International Corporation
Pharmaceutical Product Development, LLC
SAS Institute, Inc.
Sciformix Corporation
Syneos Health
Turacoz